Digital diet app for people on GLP-1 therapy
Part of Hormones & metabolism clinical trials.
This study tests a smartphone app that gives dietary advice to people who are overweight or obese and also take a GLP-1 medication (like semaglutide) for weight or diabetes. The app will help you follow a healthy eating plan while using the medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 65 years old.
- You are overweight or obese and have a related health condition (like diabetes, high blood pressure, or high cholesterol).
- You are already taking or are about to start a GLP-1 medication (such as semaglutide) prescribed by your doctor.
- You own a smartphone and are willing to use a health app for the study.
- Your chronic medications (like for blood pressure or cholesterol) have been stable for the past 8 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called NNC0487-0111 to see how well it helps people with excess body weight and type 2 diabetes lose weight, compared to another medicine called semaglutide. It may be an option if you have type 2 diabetes and are looking to manage your weight.
This study tests a digital health program (app-based) to help people with type 2 diabetes better control their blood sugar. It may be a good option if you're already managing your diabetes with diet, pills, or certain medications and can use a smartphone.
This trial tests a GLP-1 medication (a drug that helps control appetite and blood sugar) combined with a lifestyle program for teens with severe obesity. The goal is to see if this approach can improve overall health and well-being.
This trial tests a smartphone-based lifestyle program to help people with newly diagnosed type 2 diabetes lose weight and improve blood sugar control. You'll get a digital program with coaching and support, instead of usual care alone.
This study tests a 4-month digital program to help people taking a GLP-1 medication (like Ozempic or Wegovy) make healthy lifestyle changes while they continue the drug. Participants will get guidance and wear a Fitbit to track activity.
This study tests if limiting when you eat and reducing starchy foods, plus using an app to guide exercise, helps control weight and blood sugar. It is for people with higher body weight and early signs of blood sugar problems.
Hear when a new Obesity (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.